Rite Aid reports 3% decrease in comps for November
CAMP HILL, Pa. — As expected, Hurricane Sandy left its mark on Rite Aid’s monthly sales as the chain reported a decline in comps for November.
The company said the 3% decrease in same-store sales for the five-week period ended Saturday included a 0.5% decrease in front-end comps and a 4.2% decrease in pharmacy comps, while same-store prescription count increased 2.2% compared with the same time last year.
The company had anticipated a negative effect from Hurricane Sandy, which hit the Northeast in October, killing dozens and leaving millions without power and forcing most retailers to temporarily close down their stores in the affected region. According to Rite Aid, the total effect of Sandy included a negative effect of 0.4% on front-end comps and 1.5% on same-store prescription count. Still, the company said last month that it did not expect Sandy to significantly affect its fiscal year 2013 sales overall.
Total drug store sales for the month decreased by 2.3%, to $2.396 billion, from $2.452 billion in November 2011.
For the 13 weeks ended on Saturday, comps decreased by 1.5%, including a 1.1% increase in front-end comps and a 2.7% decrease in pharmacy comps. Same-store prescription count increased by 3.6%. For the year to date, comps increased by 0.3%, including a 1.7% increase in front-end comps, a 0.4% decrease in pharmacy comps and a 3.5% increase in same-store prescription count.
RxAlly hires Kerr Drug executive
LEESBURG, Va. — A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.
RxAlly announced the appointment of Rebecca Chater as VP health outcomes. Chater, a pharmacist who has worked in clinical services for 20 years, will be responsible for providing leadership and clinical management of RxAlly solutions and integrating business development with clinical staff and operations.
"Rebecca’s impressive credentials and extensive track record of success speaks to both her tremendous expertise and her genuine passion for enhancing the value of community-based, patient-focused quality pharmacy care," RxAlly CEO Bruce Roberts said. "We are very fortunate to have her on board. Her role will be critical in helping RxAlly develop and implement on a national scale industry-leading clinical service programs that support RxAlly’s member pharmacies in providing the highest quality pharmacy care available."
Most recently, Chater was an EVP at Kerr Drug subsidiary Kerr Health.
Novo Nordisk to form first all-diabetes pro-cycling team
BAGSVÆRD, Denmark — Drug maker Novo Nordisk is creating what it calls the world’s first all-diabetes professional cycling team, the company said.
The Danish pharmaceutical manufacturer announced plans to create Team Novo Nordisk, a global team with more than 100 cyclists, triathletes and runners, all of whom have diabetes.
The goal is to have the athletes compete in more than 500 competitions around the world throughout 2013, with the men’s cycling team competing in races such as the USA Pro Cycling Challenge, the Tour of Britain and the Paris-Tours, with the ultimate goal of joining the Tour de France.
"As part of our long-standing Changing Diabetes program, this partnership provides a tremendous opportunity to raise awareness, and educate, empower and inspire people with diabetes," Novo Nordisk SVP global marketing and global medical affairs Jakob Riis said. "This is yet another way Novo Nordisk is striving to create more opportunities to live well with diabetes."